Literature DB >> 7011351

Quinidine determination in serum: enzyme immunoassay (EIA) V HPLC.

H R Ha, G Kewitz, M Wenk, F Follath.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7011351      PMCID: PMC1401629          DOI: 10.1111/j.1365-2125.1981.tb00543.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Reduced quinidine clearance in elderly persons.

Authors:  H R Ochs; D J Greenblatt; E Woo; T W Smith
Journal:  Am J Cardiol       Date:  1978-09       Impact factor: 2.778

2.  Quinidine kinetics in congestive heart failure.

Authors:  C T Ueda; B S Dzindzio
Journal:  Clin Pharmacol Ther       Date:  1978-02       Impact factor: 6.875

3.  Specificity of quinidine determination methods.

Authors:  T W Guentert; S Riegelman
Journal:  Clin Chem       Date:  1978-11       Impact factor: 8.327

4.  Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function.

Authors:  D E Drayer; D T Lowenthal; K M Restivo; A Schwartz; C E Cook; M M Reidenberg
Journal:  Clin Pharmacol Ther       Date:  1978-07       Impact factor: 6.875

5.  Determination of quinidine and metabolites in urine by reverse-phase high-pressure liquid chromatography.

Authors:  M R Bonora; T W Guentert; R A Upton; S Riegelman
Journal:  Clin Chim Acta       Date:  1979-02-01       Impact factor: 3.786

6.  Determination of quinidine and its major metabolites by high-performance liquid chromatography.

Authors:  T W Guentert; P E Coates; R A Upton; D L Combs; S Riegelman
Journal:  J Chromatogr       Date:  1979-01-01

7.  Quinidine pharmacokinetics in patients with cirrhosis or receiving propranolol.

Authors:  K M Kessler; W C Humphries; M Black; J F Spann
Journal:  Am Heart J       Date:  1978-11       Impact factor: 4.749

  7 in total
  1 in total

1.  Pharmacokinetics of quinidine in male patients. A population analysis.

Authors:  C N Verme; T M Ludden; W A Clementi; S C Harris
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.